Reviva Pharmaceuticals
RVPH
RVPH
23 hedge funds and large institutions have $15.4M invested in Reviva Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
6.09% more ownership
Funds ownership: 6.73% → 12.82% (+6.1%)
5% more funds holding
Funds holding: 22 → 23 (+1)
Holders
23
Holding in Top 10
–
Calls
$12.5M
Puts
$2.47M
Top Buyers
| 1 | +$4.83M | |
| 2 | +$2.47M | |
| 3 | +$467K | |
| 4 |
CG
Colony Group
Boston,
Massachusetts
|
+$363K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$247K |
Top Sellers
| 1 | -$306K | |
| 2 | -$223K | |
| 3 | -$120K | |
| 4 |
Bank of New York Mellon
New York
|
-$63K |
| 5 |
Goldman Sachs
New York
|
-$51.3K |